Bioluminescence evaluation of efficacy of oncolytic treatment with Newcastle disease virus (NDV) in malignant pleural mesothelioma.

Abstract

e14536 Background: Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that arises from multipotent cells of the pleura. Chemotherapy and radiation have very limited therapeutic effects, and average survival time after diagnosis varies between 10 and 16 months. Immunotherapy, gene therapy (oncolytic viral therapy), and photodynamic therapy… (More)

Topics

Cite this paper

@article{Silberhumer2009BioluminescenceEO, title={Bioluminescence evaluation of efficacy of oncolytic treatment with Newcastle disease virus (NDV) in malignant pleural mesothelioma.}, author={Gerd R. Silberhumer and Peter Brader and Jayme S Y Wong and Dmitriy Zamarin and Inna S Serganova and R Blasberg and P. Palese and Yieman Fong}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2009}, volume={27 15_suppl}, pages={e14536} }